Latest News

Both semiconductor companies are poised to grow at an incredible pace due to the incredible demand for memory and custom AI processors.

Investors should get comfortable owning what has become a capital-intensive business.

There are blazing deals for some of the top healthcare stocks -- companies with proven track records and dividend yields as high as 6%.

Stocks might not be as expensive as they first appear.

Both trade under their peaks. What might carry each through the rest of the decade?

The company is the leader in a key growth market.

MercadoLibre is more focused on the future than the present.

Market cap is a quick way of understanding the total size and value of a company.

These stocks offer juicy yields and attractive risk-reward profiles.

PepsiCo and Hershey sell everyday brands that can belong in a buy-and-never-sell dividend portfolio.

If you're married or have been married, here's how to find out whether you qualify for spousal benefits.

Next year's Social Security increase could exceed the 3.5% consensus estimate.

GoGold Resources (TSE:GGD) said it is advancing construction at its Los Ricos South mine in Mexico after receiving its permit in June, while pursuing a phased development strategy for the larger Los Ricos North project. The company said it remains committed to operating in Mexico despite some indus

One digital asset treasury company is very bullish about Ethereum right now.

Weekends would add 40% more trading hours. Would revenue follow?

Nvidia's close relationship with SK Hynix benefits both companies.

Partially or fully banning diesel exports would backfire in three separate ways.

This company is the backbone of the AI infrastructure trade.

The S&P 500 has continued its march higher.

Contango ORE (NYSEAMERICAN:CTGO) outlined a five-year plan to increase its attributable production from approximately 60,000 ounces of gold to 200,000 ounces of gold and 5 million ounces of silver, with growth expected to come primarily from its Johnson Tract and Kitsault projects. The company said

These two Canadian dividend stocks offer an attractive mix of dividend income and future growth, making both worth a closer look for long-term investors.

Can the rocket and AI giant post a $10.4 billion quarter by the end of 2027?

And it's not the one you're probably thinking of.

Connect Biopharma (NASDAQ:CNTB) reported top-line results from its Seabreeze STAT Phase II study of rademikibart in patients experiencing acute exacerbations of chronic obstructive pulmonary disease, or COPD. The company said the study met its primary objective, showing reductions in treatment failu

Soon enough, seniors could get more leeway to earn money while collecting benefits.